Key points are not available for this paper at this time.
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Building similarity graph...
Analyzing shared references across papers
Loading...
Al B. Benson
Michael I. D’Angelica
Thomas A. Abrams
Journal of the National Comprehensive Cancer Network
University of Michigan
University of Pennsylvania
Memorial Sloan Kettering Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Benson et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69d7335cb54ccf0cfef30781 — DOI: https://doi.org/10.6004/jnccn.2023.0035
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: